Dedee Murrell

108PUBLICATIONS
248CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyPredictive and prognostic markersMolecular targetsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (108)

|Oct 06, 2026
Targeted therapies in pemphigus vulgaris: Emerging horizons beyond rituximab.

|Sep 11, 2026
Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial.

|Aug 25, 2026
Reassessing Remission in Pemphigus Vulgaris: Beyond Complete Remission Towards Meaningful Disease Control.

|Jul 22, 2026
Delgocitinib cream formulation demonstrates a dose-dependent response in adults with mild to severe atopic dermatitis: results from an 8-week randomised Phase IIb trial.

|Jul 13, 2026
Bullous Pemphigoid Disease Area Index Pruritus, Activity, and Damage During Biologic Therapy in Bullous Pemphigoid: An International Dual-Center Study.

|Jul 03, 2026
Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials.

Pageof 18

Frequent Collaborators

9 joint publications

Anna Wilson

8 joint publications

Aikaterini Patsatsi

8 joint publications

Enno Schmidt

8 joint publications

Maryam Daneshpazhooh